These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 11726974)
1. SCAP ligands are potent new lipid-lowering drugs. Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974 [TBL] [Abstract][Full Text] [Related]
2. A new feature on the cholesterol-lowering landscape. Rader DJ Nat Med; 2001 Dec; 7(12):1282-4. PubMed ID: 11726962 [No Abstract] [Full Text] [Related]
3. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells. Abidi P; Zhang F; Li C; Liu J Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines. Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199 [TBL] [Abstract][Full Text] [Related]
5. Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene. Nakajima T; Hamakubo T; Kodama T; Inazawa J; Emi M J Hum Genet; 1999; 44(6):402-7. PubMed ID: 10570913 [TBL] [Abstract][Full Text] [Related]
6. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889 [TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M. Liu J; Zhang F; Li C; Lin M; Briggs MR Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):90-6. PubMed ID: 12524230 [TBL] [Abstract][Full Text] [Related]
8. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells. Sekar N; Veldhuis JD Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia. Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609 [TBL] [Abstract][Full Text] [Related]
10. Transcription factor sterol regulatory element binding protein 2 regulates scavenger receptor Cla-1 gene expression. Tréguier M; Doucet C; Moreau M; Dachet C; Thillet J; Chapman MJ; Huby T Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2358-64. PubMed ID: 15486308 [TBL] [Abstract][Full Text] [Related]
11. Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols. Yabe D; Xia ZP; Adams CM; Rawson RB Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16672-7. PubMed ID: 12482938 [TBL] [Abstract][Full Text] [Related]
12. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta. Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127 [TBL] [Abstract][Full Text] [Related]
13. Effects of fibrillar C-terminal fragment of cleaved alpha1-antitrypsin on cholesterol homeostasis in HepG2 cells. Janciauskiene S; Lindgren S Hepatology; 1999 Feb; 29(2):434-42. PubMed ID: 9918920 [TBL] [Abstract][Full Text] [Related]
14. The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking. Zhang J; Dudley-Rucker N; Crowley JR; Lopez-Perez E; Issandou M; Schaffer JE; Ory DS J Lipid Res; 2004 Feb; 45(2):223-31. PubMed ID: 14617742 [TBL] [Abstract][Full Text] [Related]
15. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Yeh M; Cole AL; Choi J; Liu Y; Tulchinsky D; Qiao JH; Fishbein MC; Dooley AN; Hovnanian T; Mouilleseaux K; Vora DK; Yang WP; Gargalovic P; Kirchgessner T; Shyy JY; Berliner JA Circ Res; 2004 Oct; 95(8):780-8. PubMed ID: 15388640 [TBL] [Abstract][Full Text] [Related]
16. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB. Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918 [TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol. Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503 [TBL] [Abstract][Full Text] [Related]
19. [SCAP: a polytopic membrane protein that modulates the sterol regulated cleavage of SREBPs]. Sakai J Nihon Rinsho; 2001 Feb; 59 Suppl 2():270-6. PubMed ID: 11351587 [No Abstract] [Full Text] [Related]
20. CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin. Osborne TF Genes Dev; 2001 Aug; 15(15):1873-8. PubMed ID: 11485982 [No Abstract] [Full Text] [Related] [Next] [New Search]